A LEADING Liverpool charity last night claimed a delay in the decision to provide a lung cancer drug on the NHS is costing lives. NICE (National Institute for Clinical Excellence) has failed to decide the result of an appeal held in June, which contested their recommendation that the drug Tarceva should not be prescribed on the national health.
Link to Article
Cancer drug delay ‘costing lives’ - Liverpool Daily Post 27th September 2007
Friday, September 28, 2007
Subscribe to:
Post Comments (Atom)
1 comments:
All the best.
Post a Comment